{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:07:22Z","timestamp":1789110442740,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0551104"],"award-info":[{"award-number":["2025ZD0551104"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023ZD26"],"award-info":[{"award-number":["ZR2023ZD26"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2026QC1769"],"award-info":[{"award-number":["ZR2026QC1769"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023LZL001"],"award-info":[{"award-number":["ZR2023LZL001"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030082"],"award-info":[{"award-number":["82030082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272845"],"award-info":[{"award-number":["82272845"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218787","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:54:20Z","timestamp":1787640860000},"page":"218787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Arginine methyltransferase PRMT3 suppresses tumor-intrinsic immunity via promoting cGAS methylation"],"prefix":"10.1016","volume":"659","author":[{"given":"Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7924-6500","authenticated-orcid":false,"given":"Jianfeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7380-5510","authenticated-orcid":false,"given":"Xiangjiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218787_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218787_bib2","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218787_bib3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218787_bib4","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218787_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrc3670","article-title":"Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy","volume":"14","author":"Coulie","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218787_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218787_bib7","article-title":"Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy","volume":"11","author":"Liu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218787_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153437","article-title":"Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses","volume":"132","author":"Yan","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218787_bib9","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1038\/s44318-024-00217-y","article-title":"Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity","volume":"43","author":"Wang","year":"2024","journal-title":"Embo j"},{"key":"10.1016\/j.canlet.2026.218787_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218787_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrc3246","article-title":"The determinants of tumour immunogenicity","volume":"12","author":"Blankenstein","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218787_bib12","article-title":"MYC activation impairs cell-intrinsic IFN\u03b3 signaling and confers resistance to anti-PD1\/PD-L1 therapy in lung cancer","volume":"4","author":"Alburquerque-Bejar","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218787_bib13","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.immuni.2017.11.016","article-title":"Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA","volume":"47","author":"Coelho","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218787_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41417-022-00464-3","article-title":"Protein post-translational modifications in the regulation of cancer hallmarks","volume":"30","author":"Wang","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2026.218787_bib15","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1017\/erm.2021.4","article-title":"Methylation multiplicity and its clinical values in cancer","volume":"23","author":"Dai","year":"2021","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.canlet.2026.218787_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm.2017.35","article-title":"The winding path of protein methylation research: milestones and new frontiers","volume":"18","author":"Murn","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218787_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrm3915","article-title":"Non-histone protein methylation as a regulator of cellular signalling and function","volume":"16","author":"Biggar","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218787_bib18","doi-asserted-by":"crossref","first-page":"32974","DOI":"10.1074\/jbc.M006445200","article-title":"PRMT3 is a distinct member of the protein arginine N-methyltransferase family. Conferral of substrate specificity by a zinc-finger domain","volume":"275","author":"Frankel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218787_bib19","doi-asserted-by":"crossref","first-page":"16935","DOI":"10.1074\/jbc.273.27.16935","article-title":"PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation","volume":"273","author":"Tang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218787_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216008","article-title":"Protein arginine methyltransferase 3: a crucial regulator in metabolic reprogramming and gene expression in cancers","volume":"554","author":"Hsu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218787_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semcancer.2021.03.015","article-title":"Coordinated methyl readers: functional communications in cancer","volume":"83","author":"Park","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2026.218787_bib22","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1096\/fj.201902569R","article-title":"Zebrafish prmt3 negatively regulates antiviral responses","volume":"34","author":"Zhu","year":"2020","journal-title":"Faseb j"},{"key":"10.1016\/j.canlet.2026.218787_bib23","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1073\/pnas.1522372113","article-title":"Asymmetric arginine dimethylation of RelA provides a repressive mark to modulate TNF\u03b1\/NF-\u03baB response","volume":"113","author":"Reintjes","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218787_bib24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41419-022-05389-1","article-title":"PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism","volume":"13","author":"Liao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218787_bib25","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41467-023-38443-3","article-title":"PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218787_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1834","article-title":"Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response","volume":"7","author":"Ma","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218787_bib27","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/15548627.2022.2139921","article-title":"Tegument protein UL21 of alpha-herpesvirus inhibits the innate immunity by triggering CGAS degradation through TOLLIP-Mediated selective autophagy","volume":"19","author":"Ma","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218787_bib28","first-page":"647","article-title":"Computational prediction of methylation types of covalently modified lysine and arginine residues in proteins","volume":"18","author":"Deng","year":"2017","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.canlet.2026.218787_bib29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41416-021-01488-6","article-title":"Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience","volume":"125","author":"Rose","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218787_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz3577","article-title":"Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer","volume":"12","author":"Subudhi","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218787_bib31","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1158\/1078-0432.CCR-22-0923","article-title":"Transcriptomic correlates of tumor cell PD-L1 expression and response to nivolumab monotherapy in metastatic clear cell renal cell carcinoma","volume":"28","author":"Denize","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218787_bib32","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1158\/1078-0432.CCR-15-2839","article-title":"Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma","volume":"22","author":"Choueiri","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218787_bib33","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218787_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.686","article-title":"Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A","volume":"12","author":"Lei","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218787_bib35","article-title":"PRMT3-Mediated arginine methylation of METTL14 promotes malignant progression and treatment resistance in endometrial carcinoma","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218787_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214956120","article-title":"Asymmetric arginine dimethylation of cytosolic RNA and DNA sensors by PRMT3 attenuates antiviral innate immunity","volume":"120","author":"Zhu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218787_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218787_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218787_bib39","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1158\/1078-0432.CCR-24-1690","article-title":"At the interface of tumor-associated macrophages and fibroblasts: immune-suppressive networks and emerging exploitable targets","volume":"30","author":"Timperi","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218787_bib40","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","article-title":"The cGAS-STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218787_bib41","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"de Mingo Pulido","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218787_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9013","article-title":"cGAS-STING-mediated DNA sensing maintains CD8(+) T cell stemness and promotes antitumor T cell therapy","volume":"12","author":"Li","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218787_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ccell.2020.11.006","article-title":"DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity","volume":"39","author":"Lu","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218787_bib44","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ccell.2023.05.005","article-title":"Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity","volume":"41","author":"Fang","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218787_bib45","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41586-024-07112-w","article-title":"The CRL5-SPSB3 ubiquitin ligase targets nuclear cGAS for degradation","volume":"627","author":"Xu","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218787_bib46","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s41419-021-04352-w","article-title":"PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1\u03b1 in colorectal cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218787_bib47","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.1038\/s41467-024-52170-3","article-title":"Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS\/STING signaling","volume":"15","author":"Shi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218787_bib48","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218787_bib49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.immuni.2022.03.007","article-title":"The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade","volume":"55","author":"Cucolo","year":"2022","journal-title":"Immunity"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:36:20Z","timestamp":1789108580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526005513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0304383526005513"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218787","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arginine methyltransferase PRMT3 suppresses tumor-intrinsic immunity via promoting cGAS methylation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218787"}}